Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1894 of 6351
-
Blood pressure drug shows promise in slowing Parkinson's progression
Disease control OngoingThe purpose of this study is to investigate the long-term effects of treatment with the selective post-synaptic a1-adrenergic blocker terazosin on serial in a population of subjects with defined pre-motor Parkinson's disease (PD) risks and abnormal imaging exams. Imaging changes …
Phase 2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a gentle cream outperform harsh acne drugs?
Symptom relief CompletedThe goal of this non-interventional, observational study is to evaluate the real-world efficacy and tolerance of a novel dermocosmetic cream containing 15% Azelaic acid and a complex of active ingredients (α-AZ cream) in patients with mild-to-moderate acne treated in routine clin…
Sponsor: ISISPHARMA • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can financial support for breast milk boost preterm Babies' brain development?
Knowledge-focused By invitation onlyThe goal of this study is to determine the long-term outcomes associated with an economic intervention that was provided to encourage mother's of very premature infants to provide mother's own milk. This study will follow children after they are discharged from the Neonatal Inten…
Sponsor: Rush University Medical Center • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New hope for recurrent glioblastoma? drug combo enters early trial
Disease control OngoingThis phase I/II trial tests the safety and side effects of atezolizumab in combination with cabozantinib and whether they work to shrink tumors in patients with glioblastoma that has come back (recurrent). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help t…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New drug cocktail shows promise for rare eye cancer that spreads to liver
Disease control CompletedSITISVEAL stablish the hypothesis that treatment with Tislelizumab + Sitravatinib will increase the Objective Response Rate in patients with Metastatic Uveal Melanoma with liver metastases, compared with the current standard of care. This is a non-randomized, single arm, multice…
Phase 2 • Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Plant-Based meals delivered to home may help prostate cancer patients fight weight gain
Disease control OngoingThe study is comparing the effect on weight of providing home-delivered whole-food, plant-based meals versus standard, general nutritional counseling to men with prostate cancer on androgen-deprivation therapy (ADT).
Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise for resistant ovarian cancer
Disease control CompletedA number of studies suggest that the combination of PARP inhibitors and antiangiogenic agents produce synergistic activities. Pamiparib is a small molecule inhibitor selectivity for both PARP1 and PARP2. Surufatinib is a novel small-molecule inhibitor that simultaneously targets …
Phase 1/2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New pill aims to quiet diabetic nerve pain
Symptom relief CompletedThe purpose of this study is to investigate the safety and efficacy of the current hard gelatin capsule formulation of NRD135S.E1 80 mg once daily in the treatment of PDPN when administered for 13 weeks.
Phase 2 • Sponsor: James P. Rathmell, MD • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New hope for Hard-to-Treat cancers: drug targets KRAS G12D mutation
Disease control OngoingThe study is being conducted to evaluate the safety and tolerability of HRS-4642 in patients with advanced solid tumors harboring KRAS G12D mutation.To estimate the maximum tolerated dose (MTD) and/or a biologically active dose (eg, recommended phase 2 dose \[RP2D\]) within inves…
Phase 1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:00 UTC
-
Tablet tech could transform breast cancer diagnosis in nigeria
Diagnosis Recruiting nowThe purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies. Researchers will use mHealth devices to create a sustainable and practical way of training radiologists in Nigeria to perform and clinically implement US-guided breast biopsi…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Broccoli power: could a veggie extract shield smokers from cancer?
Prevention Recruiting nowThis phase II trial tests whether broccoli seed and sprout extract works to break down cancer causing substances of tobacco in heavy smokers. Smokers are at increased risk for developing lung, head and neck, and other cancers. Broccoli seed and sprout extract may help break down …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC
-
Could flickering light slow Alzheimer's? new study seeks answers
Symptom relief Recruiting nowThe ALZLIGHT STAGE III Study is a continuation of the ALZLIGHT Pilot - Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System. As with the first two stages, this study will examine whether entrainment of 40 Hz neural oscillation by novel 40 Hz Inv…
Sponsor: Zealand University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New Stent-Like device aims to seal brain aneurysms without surgery
Disease control OngoingThe objective of this study is to generate contemporaneous clinical data to facilitate a reasonable comparison of the performance of the FRED™ X™ device with the performance of the FRED™ device. The data generated from this study will be compared to the safety and effectiveness o…
Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could stem cells tame brain inflammation? new study tracks Real-World results
Disease control OngoingThis is a prospective, non-randomized, observational registry study evaluating the clinical outcomes of patients with autoimmune or post-infectious neuroinflammatory syndromes receiving stem cell-derived biologics (including mesenchymal stem cells and exosomes) at Biocells Medica…
Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 26, 2026 14:12 UTC
-
New drug combo aims to boost chemoradiation for head and neck cancer
Disease control Recruiting nowThis phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy ("chemo-radiation") in patients with head and neck cancer. Ipatasertib is in a class of medications called prote…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Experimental drug combo targets tough brain cancers
Disease control CompletedThe aim of this clinical trial is to evaluate the safety, preliminary effectiveness, and pharmacokinetic profiles of SM-1 (Obitrexate Fumarate Enteric-coated Pellet Capsules) combined with temozolomide, and conduct systematic dose exploration for the treatment of refractory or re…
Phase 1 • Sponsor: Shenzhen Zhenxing Medical Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New combo approach slashes post-surgery heart rhythm risk
Disease control CompletedPostoperative atrial fibrillation (POAF) is a common complication following cardiac surgery with an estimated incidence around 35%. It has been found to be an independent predictor of 30-day and 6-month mortality, stroke, renal failure, respiratory failure, and need for permanent…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a smartphone-guided exercise program help people with Parkinson's walk better and stay active?
Disease control CompletedThis study aims to determine the effects of a motor-cognitive exercise intervention, delivered in the home environment using eHealth methods, among people with Parkinson's disease. The intervention will support and motivate motor training, combined with cognitive training, aimed …
Sponsor: Stiftelsen Stockholms Sjukhem • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Heart shield: statins may keep cancer therapy on track
Disease control Recruiting nowThis study proposes that the addition of statins reduces the treatment delays or early discontinuations secondary to cardiotoxicity in patients with Stage I-III HER2 positive breast being treated with anti-HER2 therapy.
Phase 2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a simple diet prevent Crohn's Flare-Ups after surgery?
Disease control Recruiting nowOver the past 10 years, there are a large number of dietary treatments related to the CD, such as specific carbohydrate diet, low Fermentable Oligo-, Di-, Mono-saccharides And Polyols (FODMAP) diet, and allergen-free foods. But there is no consistent conclusion or convincing evid…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC